Population-level data on COVID-19 vaccine uptake in pregnancy and SARS-CoV-2 infection
outcomes are lacking. We describe COVID-19 vaccine uptake and SARS-CoV-2 infection in …

Since the first reported case of coronavirus disease 2019 (COVID-19), there have been
more than 201 million people infected globally, leading to more than 4.27 million deaths up …

Pregnant women continue to be excluded from most clinical trials of COVID-19 vaccines and
medication, despite very clear pre-pandemic guidance. 1 There appears little incentive …

Background COVID-19 in pregnant people increases the risk for poor maternal–fetal
outcomes. However, COVID-19 vaccination hesitancy remains due to concerns over the …

Background COVID-19 vaccines are advised for pregnant women in the United Kingdom
(UK) however COVID-19 vaccine uptake among pregnant women is inadequate. Methods …

Data on the safety of COVID-19 vaccines in early pregnancy are limited. We conducted a
national, population-based, matched cohort study assessing associations between COVID …

Background Pregnant individuals have been receiving COVID-19 vaccines following pre-
authorisation clinical trials in non-pregnant people. This study aimed to determine the …

While there is no indication that pregnant women have an increased susceptibility to
infection with SARS-CoV-2, evidence suggests that pregnant women with COVID-19 are at …

Background COVID-19 infection in pregnancy is associated with a higher risk of progression
to severe disease, but vaccine uptake by pregnant women is hindered by persistent safety …

Background Concerns have been raised regarding a potential surge of COVID-19 in
pregnancy, secondary to the rising numbers of COVID-19 in the community, easing of …